Scientifically optimised for a better life
Medlab Clinical Ltd (ASX: MDC) is an Australian, publicly listed biotechnology company that is finding new ways to address the biggest challenges of our time including the growing burden of cancer, suboptimal pain management as well as enhancing drug delivery with nanotechnology.
Medlab has a portfolio of novel therapeutics solutions (both over the counter and prescription), with the lead product for pain management advancing towards Phase III trials.
Medlab also has a patented drug delivery platform called NanoCelle® in the market that improves drug solubility issues and enables faster absorption. The unique platform supports Medlab’s mission to improve patients' quality of life and health outcomes globally.
Together, we will deliver more for human health and beyond.
PC2 LAB - 3D TOUR